Study Detail

TitleGenomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer
Study TypeOther
Abstract The molecular landscape underpinning response to the AR-antagonist enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) is unclear. Since mCRPC tissue biopsies are frequently impractical, we collected temporal circulating cell-free DNA (cfDNA) samples from 65 mCRPC patients receiv .. [more]
Description The molecular landscape underpinning response to the AR-antagonist enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) is unclear. Since mCRPC tissue biopsies are frequently impractical, we collected temporal circulating cell-free DNA (cfDNA) samples from 65 mCRPC patients receiv .. [more]
Center NameInstitute of Biosciences and Medical Technology